Massachusetts Institute of Technology
Sign in

What Can We Learn From Related Industries?

08/12/2004 3:15PM Wong Auditorium
Scott Sarazen, Senior Vice President, Life Sciences, MassDevelopment; Andrew Parece, Vice President, Analysis Group/Economics Analysis Group, Inc; Tamsin S. Randlett, Senior Director, Government Affairs, Gap Inc. ; Stephen M. Sammut, Venture Partner, Burrill & Company

Description: In some ways, the pharmaceutical industry is unique from other industries, its upfront R&D costs, for instance are extremely high. But these panelists see some commonalities with other business sectors, and offer observations and counsel to drug manufacturers. Andrew Parece focuses on the trade of high tech goods, such as software, digital cameras and DVDs. There are difficulties controlling the free flow of these goods, and their prices, across borders a challenge the drug industry also confronts today. Parece suggests that pharma companies "leverage their competitive advantage 'to differentiate products, and turn offerings into products and services such as patient assistance and education, and disease management." Tamsin Randlett of Gap, Inc. deals more with issues on the manufacturing end. The Gap outsources clothing production to companies in parts of the world where wage and labor standards lag. To respond to concerns about equity and human rights, Randlett partners with international labor organizations and NGOs. She suggests pharmaceutical industries similarly "leverage world health organizations 'to bring greater credibility to your efforts" and sit down with politicians, even those opposed to industry positions. Stephen Sammut's venture capital group invests in the biosecurity business. Just as in drug manufacturing, biosecurity involves risky and expensive R&D, licensing and liability questions, and unpredictable market size. Since "northern hemisphere concerns about biosecurity are the daily disease burden of many countries in the southern hemisphere," says Sammut, one answer to the pricing problem may be creating drugs useful for both markets simultaneously.

Host(s): Sloan School of Management, MIT Sloan School of Management

Comments (0)

It looks like no one has posted a comment yet. You can be the first!

You need to log in, in order to post comments.

MIT World — special events and lectures

MIT World — special events and lectures

Category: Events | Updated 3 months ago

Created
December 13, 2011 11:18
Category
Tags
License
All Rights Reserved (What is this?)
Additional Files


Viewed
2870 times

More from MIT World — special events and lectures

Investments in our Future: Exploring Space through Innovation and Technology

Investments in our Future: Explorin...

Added 4 years ago | 01:18:00 | 8246 views

The Second Law and Energy Panel

The Second Law and Energy Panel

Added 4 years ago | 01:30:00 | 5356 views

Energy Education Showcase: How MIT is Preparing Students for New Challenges

Energy Education Showcase: How MIT ...

Added 4 years ago | 01:12:00 | 5130 views

Transportation in Contemporary Society: A Complex Systems Approach

Transportation in Contemporary Soci...

Added 4 years ago | 01:05:00 | 7159 views

Toying with Transmedia: The Future of Entertainment is Child's Play

Toying with Transmedia: The Future ...

Added 4 years ago | 00:51:18 | 12021 views

Animal Models of Cancer

Animal Models of Cancer

Added 4 years ago | 01:05:00 | 3001 views